check_circleStudy Completed

Magnetic Resonance Imaging, Kidney Neoplasms

Bayer Identifier:

90931

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
MRI study of 1.0 molar Gadobutrol and 0.5 molar Gd-DTPA with a single i.v. injection in patients with known or suspected renal lesions

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
471
Trial Dates
May 2002 - May 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Gadavist/Gadovist (Gadobutrol, BAY86-4875)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

A multicenter, single-blind, randomized, inter-individually controlled MRI study of 1.0 molar gadobutrol and 0.5 molar Gd-DTPA with a single i.v. injection in patients with known or suspected renal lesions
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.